TGA
·health
·13 hours ago
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal Share LinkedIn (Twitter) Facebook Email On 20 May 2026, the provisional registration of AstraZeneca Pty Ltd’s ANDEXXA (andexanet alfa) lapsed. This means ANDEXXA is no longer provisionally approved for use in Australia and has been removed from the Australian Register of Therapeutic Goods (ARTG).
Summary by Glance · TGA
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI